Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More

Pfizer’s Results, What’s Next for Retail & Re...

Up next

DigitalOcean (DOCN) & Honeywell (HON): New Watch List Picks

Simon Erickson adds two new companies to 7investing’s October 2026 watch list, both tackling one of the biggest bottlenecks in AI infrastructure: data center efficiency. DigitalOcean (NYSE: DOCN) is building an “AI-native cloud” that lets enterprises route requests across multipl ...  Show more

Veeva Systems (VEEV) Up 77%: What We Learned

Veeva Systems (NYSE: VEEV) was a 7investing Best Buy three months in a row back in the summer of 2026, and the stock is up more than 77% since. Simon Erickson breaks down what made Veeva a buying opportunity when it fell 40% on news of its migration away from the Salesforce (NYSE ...  Show more

Recommended Episodes

A Vaccine Boost
Motley Fool Hidden Gems Investing

Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ...  Show more

Market Reaction to COVID Lockdowns and Developments, a Record High for the Nasdaq, The EV Space’s Week for the Ages and the House Passes Pres. Biden's $1.7T Social Spending Package
Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discussed market worries about COVID-19, with Austria announcing a nationwide lockdown while Germany tried to tamp down fears that it would follow suit. But in the U.S., FDA authorized use of Pfizer and Moderna's COVID vaccine booster ...  Show more

COVID-19 Vaccine Optimism, Business Leaders' Message To President Trump, And Retail Stocks' Big November Rally
Squawk on the Street

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

  Show more